Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison between Overall, Cause-specific, and Relative Survival Rates Based on Data from a Population-based Cancer Registry

  • Published : 2012.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Three kinds of survival rates are generally used depending on the purpose of the investigation: overall, cause-specific, and relative. The differences among these 3 survival rates are derived from their respective formulas; however, reports based on actual cancer registry data are few because of incomplete information and short follow-up duration recorded on cancer registration. The aim of this study was to numerically and visually compare these 3 survival rates on the basis of data from the Nagasaki Prefecture Cancer Registry. Subjects were patients diagnosed with cancer and registered in the registry between 1999 and 2003. We calculated the proportion of cause of death and 5-year survival rates. For lung, liver, or advanced stage cancers, the proportions of cancer-related death were high and the differences in survival rates were small. For prostate or early stage cancers, the proportions of death from other causes were high and the differences in survival rates were large. We concluded that the differences among the 3 survival rates increased when the proportion of death from other causes increased.

Keywords

References

  1. Ajiki W, Matsuda T, Sato T, et al (1998). A standard method of calculating survival rates in population-based cancer registries. Jpn J Cancer Clin, 44, 981-93.
  2. Brown BW, Brauner C, Minnotte MC (1993). Noncancer deaths in white adult cancer patients. J Natl Cancer Inst, 85, 979-87. https://doi.org/10.1093/jnci/85.12.979
  3. Coleman MP, Forman D, Bryant F, et al (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet, 377, 127-38. https://doi.org/10.1016/S0140-6736(10)62231-3
  4. Coleman MP, Quaresma M, Berrino F, et al (2008). Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol, 9, 730-56. https://doi.org/10.1016/S1470-2045(08)70179-7
  5. Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med, 19, 1729-40. https://doi.org/10.1002/1097-0258(20000715)19:13<1729::AID-SIM484>3.0.CO;2-9
  6. Curado MP, Edwards B, Shin HR, et al (2007). Cancer Incidence in Five Continents vol IX. 16th edition of IARC Scientific Publications, Lyon.
  7. Gamel JW, Vogel RL (2001). Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients. Stat Methods Med Res, 10, 339-52. https://doi.org/10.1191/096228001680678331
  8. Gerber GS, Thompson IM, Thisted R, Chodak GW (1993). Disease-specific survival following routine prostate cancer screening by digital rectal examination. JAMA, 269, 61-4. https://doi.org/10.1001/jama.1993.03500010071034
  9. Hakulinen T (1997). On long-term relative survival rates. J Chron Dis, 30, 431-43.
  10. Heinavaara S, Teppo L, Hakulinen T (2002). Cancer-specific survival of patients with multiple cancers: an application to patients with multiple breast cancers. Stat Med, 21, 3183-95. https://doi.org/10.1002/sim.1247
  11. Henson DE, Ries LA (1995). The relative survival rate. Cancer, 76, 1687-8. https://doi.org/10.1002/1097-0142(19951115)76:10<1687::AID-CNCR2820761002>3.0.CO;2-I
  12. Henson DE, Ries LAG (1994). On the estimation of survival. Semin Surg Oncol, 10, 2-6. https://doi.org/10.1002/ssu.2980100103
  13. Kroeger N, Ranpersaud EN, Patard JJ, et al (2012). Prognostic value of microvascular invasion in the occurrence of cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. J Urol, 187, 418-23. https://doi.org/10.1016/j.juro.2011.10.024
  14. Matsuda T, Ajiki W, Marugame T, et al (2011). Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol, 41, 40-51. https://doi.org/10.1093/jjco/hyq167
  15. Ministry of Health, Labour and Welfare (2010). Abridged life tables in Japan for 1962-2010. Tokyo: Canter for Cancer Control and Information Service, National Cancer Center. [Cited 1 Sep 2010] Available at: http://ganjoho.jp/professional/statistics/cohort01.html (in Japanese).
  16. Parkin DM, Hakulinen H (1991). Analysis of survival. In 'Cancer Registration: Principles and Methods', Eds Jensen OM, Parkin DM, MacLennan R, Muir CS, and Skeet RG. IARC Scientific Publications, Lyon pp 159-76.
  17. Tanaka H, Tanaka M, Chen W, et al (2009). Proposal for a cooperative study on population-based cancer survival in selected registries in East Asia. Asian Pac J Cancer Prev, 10, 1191-8.
  18. Tsukuma H, Ajiki W, Ioka A, Oshima A, Research Group of Population-Based Cancer Registries of Japan (2006). Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol, 36, 602-7. https://doi.org/10.1093/jjco/hyl068
  19. Yu B, Tiwati RC, Feuer EJ (2011). Estimating the personal cure rate of cancer patients using population-based cancer survival data. Stat Methods Med Res, 20, 261-74. https://doi.org/10.1177/0962280209347046

Cited by

  1. Breast cancer survival in New Zealand women vol.85, pp.7-8, 2015, https://doi.org/10.1111/ans.12851
  2. Relative Survival of Breast Cancer Patients in Iran vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5853
  3. Breast Cancer Characteristics and Survival Differences between Maori, Pacific and other New Zealand Women Included in the Quality Audit Program of Breast Surgeons of Australia and New Zealand vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2465